login
login
Image header Agence Europe
Europe Daily Bulletin No. 13195
Contents Publication in full By article 19 / 33
SECTORAL POLICIES / Health

European Commission authorises first vaccine to protect older adults from respiratory syncytial virus

The European Commission announced, on Tuesday 6 June, that it had authorised Arexvy, the first vaccine designed to protect adults aged 60 and over against lower respiratory tract disease caused by the respiratory syncytial virus (RSV).

The Arexvy vaccine, which is now authorised throughout the EU, will help strengthen the immune response to the virus. The authorisation follows a rigorous assessment under the European Medicines Agency’s (EMA) accelerated assessment mechanism. Considering...

Contents

EXTERNAL ACTION
Russian invasion of Ukraine
SECTORAL POLICIES
ECONOMY - FINANCE - BUSINESS
SOCIAL AFFAIRS - EMPLOYMENT
SECURITY - DEFENCE
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
INSTITUTIONAL
COURT OF JUSTICE OF THE EU
NEWS BRIEFS